Evidence-based indications for the use of PET-CT in the United Kingdom 2022

Since its introduction into the UK clinical practice in 1992 by Professor Michael Maisey, PET, followed by positron emission tomography-computed tomography (PET-CT), has become a key multimodality molecular imaging technique in the assessment of a wide range of medical conditions. Now in its fourth edition, this 2022 document provides updated indications with key references underpinning the use of fluorodeoxyglucose (FDG) and non-FDG PET-CT tracers in malignant and non-malignant diseases in clinical practice.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.